DE69415462D1 - Synthetischen peptiden und impfstoffe gegen parvovirus - Google Patents

Synthetischen peptiden und impfstoffe gegen parvovirus

Info

Publication number
DE69415462D1
DE69415462D1 DE69415462T DE69415462T DE69415462D1 DE 69415462 D1 DE69415462 D1 DE 69415462D1 DE 69415462 T DE69415462 T DE 69415462T DE 69415462 T DE69415462 T DE 69415462T DE 69415462 D1 DE69415462 D1 DE 69415462D1
Authority
DE
Germany
Prior art keywords
parvoviruses
synthetic peptides
peptides
vaccine against
against parvovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69415462T
Other languages
English (en)
Other versions
DE69415462T2 (de
Inventor
Alvarez Jose Casal
Olmo Carmen Vela
Joannes Langeveld
Robert Meloen
Kristian Dalsgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmunologia y Genetica Aplicada SA
Original Assignee
Inmunologia y Genetica Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES9300117A external-priority patent/ES2065254B1/es
Priority claimed from ES9400111A external-priority patent/ES2089966B1/es
Application filed by Inmunologia y Genetica Aplicada SA filed Critical Inmunologia y Genetica Aplicada SA
Publication of DE69415462D1 publication Critical patent/DE69415462D1/de
Application granted granted Critical
Publication of DE69415462T2 publication Critical patent/DE69415462T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE69415462T 1993-01-23 1994-01-21 Synthetischen peptiden und impfstoffe gegen parvovirus Expired - Lifetime DE69415462T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES9300117A ES2065254B1 (es) 1993-01-23 1993-01-23 Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
ES9400111A ES2089966B1 (es) 1994-01-20 1994-01-20 Peptidos y vacunas sinteticas contra parvovirus.
PCT/ES1994/000006 WO1994017098A1 (es) 1993-01-23 1994-01-21 Peptidos y vacunas sinteticos contra parvovirus

Publications (2)

Publication Number Publication Date
DE69415462D1 true DE69415462D1 (de) 1999-02-04
DE69415462T2 DE69415462T2 (de) 1999-07-15

Family

ID=26154691

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69415462T Expired - Lifetime DE69415462T2 (de) 1993-01-23 1994-01-21 Synthetischen peptiden und impfstoffe gegen parvovirus

Country Status (10)

Country Link
US (1) US5785974A (de)
EP (1) EP0647655B1 (de)
AT (1) ATE174929T1 (de)
AU (1) AU680264B2 (de)
CA (1) CA2132742C (de)
DE (1) DE69415462T2 (de)
DK (1) DK0647655T3 (de)
GR (1) GR3029727T3 (de)
NZ (1) NZ259882A (de)
WO (1) WO1994017098A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2026826A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
ES2109189B1 (es) * 1996-03-14 1998-05-16 Iberica Cyanamid Vectores basados en genomas virales defectivos recombinantes y su empleo en la formulacion de vacunas.
WO1997040163A1 (en) * 1996-04-19 1997-10-30 Metin Colpan Nucleic acid vaccination for parvoviral infections
WO1997049425A1 (en) * 1996-06-25 1997-12-31 Stichting Instituut Voor Dierhouderij En Diergezondheid Vaccine comprising antigens bound to carriers through labile bonds
US6914131B1 (en) * 1998-10-09 2005-07-05 Chiron S.R.L. Neisserial antigens
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
GB9911683D0 (en) * 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
BR0108711A (pt) * 2000-02-28 2004-06-22 Chiron Spa Expressão heteróloga de proteìnas de neisseria
US6730306B1 (en) * 2000-03-08 2004-05-04 Large Scale Biology Corporation Parvovirus vaccine as viral coat protein fusions
JPWO2017217460A1 (ja) * 2016-06-15 2019-04-04 出光興産株式会社 ペプチドリンカーで連結された２以上のタンパク質を含む融合タンパク質
CN107827958B (zh) * 2017-11-11 2020-08-25 中牧实业股份有限公司 犬细小病毒合成肽疫苗及其制备方法和应用
CN116102660B (zh) * 2022-09-19 2023-11-21 扬州优邦生物药品有限公司 一种猪细小病毒基因工程表位疫苗及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117767A1 (de) * 1983-01-07 1984-09-05 Mgi Pharma, Inc. Herstellung von Untereinheiten von Parvovirus-Vakzinen
IL70704A0 (en) * 1983-01-19 1984-04-30 Amgen Methods and materials for development of parvovirus vaccines
DE3939470A1 (de) * 1989-11-29 1991-06-06 Biochrom Beteiligungs Gmbh & C Peptide und antikoerper gegen peptide, welche zur diagnose und zur verhuetung der b19-infektion verwendbar sind
DE4003826C2 (de) * 1990-02-08 1995-11-23 Mikrogen Molekularbiol Entw Peptide der Kapsidproteine VP1 oder VP2 des Parvovirus B19
ES2026827A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
ES2026826A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
AU2347692A (en) * 1991-07-09 1993-02-11 Cornell Research Foundation Inc. Recombinant viral vaccine

Also Published As

Publication number Publication date
GR3029727T3 (en) 1999-06-30
NZ259882A (en) 1997-03-24
CA2132742A1 (en) 1994-07-24
EP0647655A1 (de) 1995-04-12
AU7004894A (en) 1994-08-15
US5785974A (en) 1998-07-28
AU680264B2 (en) 1997-07-24
CA2132742C (en) 2000-04-18
EP0647655B1 (de) 1998-12-23
DK0647655T3 (da) 1999-08-23
ATE174929T1 (de) 1999-01-15
WO1994017098A1 (es) 1994-08-04
DE69415462T2 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
BR9605153B1 (pt) vacina de combinação, e, kit de vacinação.
DE69535530D1 (de) Impfstoff und Antitoxine zur Behandlung und Vorbeugung von C. Difficile Krankheiten
ATE188612T1 (de) Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend
DE69415462T2 (de) Synthetischen peptiden und impfstoffe gegen parvovirus
ATE229978T1 (de) Helicobacter proteine und impstoffe
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
ZA975618B (en) Avian recombinant live vaccine using as vector the avian infectious laryngotrachetis virus
ATE350390T1 (de) Synthetische peptide und impfstoffe welche diese beinhalten
FR2670787B1 (fr) Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins.
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
ATE287957T1 (de) Peptide abgeleitet vom bindungs (g) protein des respiratorisches synzytialvirus
DK1499349T3 (da) Rekombinante hybrid-allergenkonstrukter med reduceret allergenitet, der bibeholder det naterulige allergens immunogenitet
SE9604296D0 (sv) New pharmaceutical formulation of polypeptides
WO1993014206A3 (en) Synthetic peptides for a rubella vaccine
DK0535740T3 (da) Vaccine mod luftvejsinfektioner hos katte
DK204588A (da) Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
ES2065254A1 (es) Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
ES2089966A1 (es) Peptidos y vacunas sinteticas contra parvovirus.
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
ES1027961U (es) Soporte publicitario para carritos.
PT91600A (pt) Vaccinal polypeptides
ATE102252T1 (de) Rekombinantes gefluegelpockenvirus, expressionsvektoren fuer heterologische proteine und davon derivierte gefluegelvakzine.
RU94018276A (ru) Штамм бактерий l.monocytogenes усхи-52, используемый для изготовления листериозной вакцины

Legal Events

Date Code Title Description
8364 No opposition during term of opposition